1-((S)-3-methyl-2-(((2S,3S)-3-propylcarbamoyl-oxiranecarbonyl)-amino)-pentanoyl)-pyrrolidine-2-carboxylic acid,
CA 074,
CA-074,
N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,
nPrHN-(2S,3S)-tEps-Ile-Pro-OH,
CA-074,
134448-10-5,
CA 074,
CHEMBL490920,
MFCD00797531,
PrNH-tES-Ile-Pro-OH,
epoxysuccinyl derivative CA074,
SCHEMBL4323476,
(L-3-trans-(Propylcarbamyl)oxirane-2-carbonyl)-L-isoleucyl-L-proline,
BDBM16509,
CA074,
ZINC3927825,
AKOS024458382,
CS-7886,
HY-103350,
N-[[(2S,3S)-3-[(Propylamino)carbonyl]-2-oxiranyl]carbonyl]-L-isoleucyl-L-proline,
N-{[(2S,3S)-3-(propylcarbamoyl)oxiran-2-yl]carbonyl}-L-isoleucyl-L-proline,
(2S)-1-[(2S,3S)-3-methyl-2-{[(2S,3S)-3-(propylcarbamoyl)oxiran-2-yl]formamido}pentanoyl]pyrrolidine-2-carboxylic acid,
Cathepsin B Inhibitor III,
PBCM 074,
ZEZGJKSEBRELAS-PEDHHIEDSA-N,
C18H29N3O6,
nPrHN-(2S,3S)-tEps-Ile-Pro-OH,
C18-H29-N3-O6,
CID9821383,
A1926,
A13256,
N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,